Skip to content
← Full study record

NCT00387335 · MORE INFO

Limitations, agreements, and source contact

Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer · Source last updated 2014-07-25

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
ecohen@medicine.bsd.uchicago.edu
organization
University of Chicago
phone
773-702-4137
title
Ezra Cohen
Complete source fields
certain Agreement
pi Sponsor Employee
false
restriction Type
LTE60
restrictive Agreement
true
point Of Contact
email
ecohen@medicine.bsd.uchicago.edu
organization
University of Chicago
phone
773-702-4137
title
Ezra Cohen

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice